Proposed Combination Between Essilor and Luxottica Approved in Canada

Tuesday, November 28 2017 | 00 h 00 min | News, Press Release

Charenton-le-Pont, France and Milan, Italy – Essilor and Luxottica today announced the proposed combination between the two companies has been cleared by the Canadian Competition Bureau. Canada is one of the five jurisdictions where antitrust approvals are a condition precedent to the closing of the transaction.

The transaction has been cleared so far in ten other jurisdictions: Australia, Colombia, India, Japan, Morocco, New Zealand, Russia, South Africa, South Korea and Taiwan.

Click HERE for press release.

Featured Posts

Two-Year Clinical Results Reinforce Long-Term Effectiveness of MyoPro® Lens

New two-year clinical results published in IOVS show that MyoPro® lenses provide sustained effectiveness in slowing myopia progression in children.

Learn More

Optik Voilàs November-December 2025- Marchon Lacoste L2316_770

Lacoste Redefines Feminine Precision

Discover the Lacoste L2316: a lightweight metal frame with a sleek feminine silhouette, laser-engraved Monogram details, and all-day comfort.

Ray-Ban ASAP Rocky Wayfarer Puffer Crystal Collection

A$AP Rocky Expands Creative Partnership with Ray-Ban, Reimagining the Wayfarer Puffer

Ray-Ban and Creative Director A$AP Rocky reveal three new takes on the Wayfarer Puffer, including Crystal, Pavé, and Diamond editions. Elevated designs, bold silhouettes, and premium detailing define the latest collaboration.

Canadian Ophthalmological Society Urges Early Detection as Diabetes Awareness Month Approaches

A new survey by the Canadian Ophthalmological Society reveals three in four Canadians are unaware diabetes can cause vision loss. The COS urges early detection during Diabetes Awareness Month to prevent diabetic retinopathy.

Time Change: What Science Just Discovered About Our Internal Clock

Researchers in Montreal have discovered how retinal glial cells help synchronize our biological clock with the day-night cycle, a finding that could lead to new treatments for circadian rhythm disorders.

Two-Year Clinical Results Reinforce Long-Term Effectiveness of MyoPro® Lens

New two-year clinical results published in IOVS show that MyoPro® lenses provide sustained effectiveness in slowing myopia progression in children.

Learn More

Lacoste Redefines Feminine Precision

Discover the Lacoste L2316: a lightweight metal frame with a sleek feminine silhouette, laser-engraved Monogram details, and all-day comfort.

A$AP Rocky Expands Creative Partnership with Ray-Ban, Reimagining the Wayfarer Puffer

Canadian Ophthalmological Society Urges Early Detection as Diabetes Awareness Month Approaches

Time Change: What Science Just Discovered About Our Internal Clock

Two-Year Clinical Results Reinforce Long-Term Effectiveness of MyoPro® Lens

New two-year clinical results published in IOVS show that MyoPro® lenses provide sustained effectiveness in slowing myopia progression in children.

Learn More

Lacoste Redefines Feminine Precision

Discover the Lacoste L2316: a lightweight metal frame with a sleek feminine silhouette, laser-engraved Monogram details, and all-day comfort.

A$AP Rocky Expands Creative Partnership with Ray-Ban, Reimagining the Wayfarer Puffer

Canadian Ophthalmological Society Urges Early Detection as Diabetes Awareness Month Approaches

Time Change: What Science Just Discovered About Our Internal Clock

Two-Year Clinical Results Reinforce Long-Term Effectiveness of MyoPro® Lens

New two-year clinical results published in IOVS show that MyoPro® lenses provide sustained effectiveness in slowing myopia progression in children.

Learn More

Lacoste Redefines Feminine Precision

Discover the Lacoste L2316: a lightweight metal frame with a sleek feminine silhouette, laser-engraved Monogram details, and all-day comfort.